Pardon the Interruption…

A bank is a place where they lend you an umbrella in fair weather and ask for it back when it rains. - Robert Frost

Ever notice how it's a penny for your thoughts, yet you put in your two-cents? Someone is making a penny on the deal! - Steven Wright

Life certainly takes its turns. With the combination of the surgery on my poor little five year old and then major computer issues over the weekend, I feel like I’m playing from behind. How do you tell a child that even though the pain medication doesn’t taste good, it will take the hurt away where they get it??? The poor child has been suffering.

Anyway, the markets have been interesting over the last week. The few people that actually paid attention on Friday showed some raw nerves with the news of Dubai. The question of the day is “are they too big to fail?”

As everybody came back to work this week, the fears of Dubai have, at least temporarily, subsided and we even had some good news today with some of the financial data released. Let’s see where our experts see opportunity.

Kelley Wright provides commentary and trade recommendations using a dividend value method to determine stock value. His publication Investment Quality Trends is released monthly and has provided quality insight for over 40 years. In his latest, “So What Do We Do Now?” find out what a “Select Blue Chip” is and learn how they have done it for four decades.

The Real Wealth Report by Larry Edelson is another monthly newsletter. This one focuses on natural resources, gold bullion and stocks as well as other precious metals. The most recent edition, “My Answers to Your Recent Questions,” he answers questions on the economy, inflation, the dollar and the idea of gold as a singular global currency.

Dan Rosenblum uncovers opportunities in a completely different space. His daily Shark Biotech gives insight and commentary on new biotech investments based on IPO status, R&D and the industry itself. Today’s alert was on Onyx Pharmaceuticals (ONXX) and whether or not their cancer drug is on a list for reimbursement in China.

There are three completely different ideas for you to review today. You could even combine the three using the first as your core with the other two satellites. So many ideas…so little time…

For more information, please go to http://www.zepinvest.com.

Print this post